Levels of Cyclosporin in Epidermis of Treated Psoriasis Patients Differentially Inhibit Growth of Keratinocytes Cultured in Serum Free Versus Serum Containing Media
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 91 (2) , 142-146
- https://doi.org/10.1111/1523-1747.ep12464387
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Cyclosporin A Does Not Inhibit Epidermal Cell Growth at Therapeutic LevelsJournal of Investigative Dermatology, 1987
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Short-term use of cyclosporin A in severe psoriasisBritish Journal of Dermatology, 1986
- Does cyclosporine act in vivo as it does in vitro?Immunology Today, 1986
- Two Functionally Distinct Classes of Growth Arrest States in Human Prokeratinocytes That Regulate Clonogenic PotentialJournal of Investigative Dermatology, 1986
- CYCLOSPORIN FOR POLYMYOSITISThe Lancet, 1984
- CYCLOSPORIN FOR CROHN'S DISEASEThe Lancet, 1984
- Cyclosporin A: Review of results in organ and bone‐marrow transplantation in manMedicinal Research Reviews, 1984
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979